It's a common error to conflate the CHIPS Act and the October 2022 chip controls. The CHIPS Act was a legislative effort for domestic manufacturing resilience. The executive export controls were a separate national security policy focused on denying China access to high-end compute for military applications.

The CHIPS Act's success came from a 'happy medium' design. Congress set a clear, bipartisan objective (semiconductors) but granted the executive team broad discretion on implementation. This structure proved more effective than an overly broad mandate (e.g., 'economic security') or overly prescriptive legislation.

Longevity advocacy succeeds by tailoring its message. To fiscal conservatives, it's a way to reduce Medicare spending. To progressive Democrats, it's about using mass-produced drugs to achieve health equity and close the gap between the wealthy and the poor.

The current trade friction is part of a larger, long-term bipartisan U.S. strategy of "competitive confrontation." This involves not just tariffs but also significant domestic investment, like the CHIPS Act, to build resilient supply chains and reduce reliance on China for critical industries, a trend expected to persist across administrations.

Major shaping legislation on China, from the CHIPS Act to sanctions, often originates in Congress. Congressional action creates durable policy that outlasts fleeting presidential administrations, providing guardrails and tools for the executive branch.

The 2022 CHIPS Act was passed months before ChatGPT's launch. The subsequent AI-driven demand for semiconductors was not the primary driver for the legislation. The Act's incentives accelerated US manufacturing capacity, luckily positioning the nation to capitalize on an unanticipated boom.

Congress consistently rejects proposals to slash NIH funding due to deep bipartisan popularity. This support is strategically reinforced by the NIH's deliberate policy of distributing research grants across the country, ensuring almost every member of Congress has a constituent institution benefiting from the funds.

Trump's praise for Intel transforms the complex CHIPS Act investment into a simple, successful financial transaction for voters ('made...tens of billions...in just four months'). This narrative bypasses nuanced policy debate, making strategic industrial policy immediately understandable and popular with the public.

AI policy has largely been bipartisan, especially on national security issues like restricting chip sales to China. However, a new partisan gap is forming, with a potential second Trump administration signaling a shift towards deregulation ("let the private sector cook") and resuming chip sales to China.